CD8A and post-transplant lymphoproliferative disease: Moosmann et al. demonstrated that CD8+ T cells after being transferred either unveiled a CCR7+CD45RA- central memory or a CCR7-CD45RA+ terminal effector phenotype and both subsets were consistent with long-term T-cell persistence and capable of controlling viral reactivations after PTLD remission [17].